Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.68 USD | -0.43% | -2.45% | +67.74% |
01/05 | Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN 1154 | CI |
12/04 | Lipocine Says LPCN 2401 Shows Improved Body Composition in Mid-Stage Trial | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- LPCN Stock
- Revisions Lipocine Inc.